News

JPMorgan Boosts Science Applications Stock to Overweight Rating

JPMorgan Boosts Science Applications Stock to Overweight Rating

JPMorgan Upgrades Science Applications International Corp

In a significant move, JPMorgan has recently upgraded Science Applications International Corp (NASDAQ:SAIC) from a Neutral rating to an Overweight rating. This upgrade reflects the firm’s growing confidence in the company's potential, raising its price target from $150.00 to an impressive $170.00. This optimistic view comes on the heels of Science Applications' strategic initiatives aimed at transitioning to higher-value services, a message strongly conveyed during their Investor Day earlier this year.

Strengthening Financial Performance

Science Applications International Corp has showcased a robust trajectory of financial growth, illustrated by a significant increase in their qualified pipeline, which has grown from approximately $115 billion in FY24 to around $130 billion currently. The company has also ramped up its submitted bids, showcasing a remarkable rise from $17 billion last year to an impressive $22 billion this year. Notably, in the first half alone, they submitted nearly $15 billion in bids, surpassing their internal goals.

Aiming for Ambitious Growth Targets

The company's leadership has set ambitious performance metrics, aiming for a new business win rate exceeding 30% and a retention rate between 80% and 90% for re-competes. By targeting these metrics, they anticipate achieving a trailing 12-month book-to-bill ratio of 1.2x by the middle of FY26. Although the company faces challenges relating to lost re-compete opportunities, affecting organic growth by about five percentage points this fiscal year, they project that these issues will diminish as they proceed into FY26.

Projected Growth and Margin Expansion

In their forecasts for FY26, Science Applications is anticipating a growth rate of 3%, coupled with a modest margin expansion of 10 basis points. JPMorgan views these projections as realistic, especially considering the potential for additional gains linked to the company's adeptness in pursuing new programs. Despite some risks associated with securing new contracts and the complexities of enhanced technical requirements, analysts indicate that there is a possibility for improved margin rates ahead.

Valuation Insights from JPMorgan

JPMorgan's analysis suggests that existing market valuations may reflect skepticism surrounding SAIC’s performance. However, the firm underscores the strong free cash flow that SAIC generates, over $500 million annually, which translates to about 7% of the company's current market capitalization. The commitment of management to return this cash to shareholders underpins a positive outlook moving forward. The targeted price of $170 by December 2025 is calculated on 16 times the estimate for adjusted EPS for FY27 (CY26).

Recent Contracts and Market Ventures

In other developments, Science Applications has been actively engaging in securing new contracts. Recently, they finalized a $229 million deal with the U.S. Department of Defense, which aims to bolster the IT capabilities of NORAD and USNORTHCOM. Furthermore, their latest fiscal quarter performance revealed a 2% increase in revenue, although EBITDA saw a 2% decline. Nevertheless, their results surpassed market expectations and led to revised forecasts for FY2025, predicting a revenue growth of 3% and an EBITDA growth of 4%.

Continued Growth and Shareholder Commitment

Science Applications is aligning its business strategies with key growth areas and improving its bidding capabilities. The ambition is to achieve a book-to-bill ratio of 1.2x by the first half of FY26, alongside a target for 5% organic revenue growth by the end of the same fiscal year. While acknowledging potential risks tied to the procurement process and external market factors, company executives remain confident in their strategic direction aimed at driving sustainable growth.

Insights from Recent Market Data

Further supporting JPMorgan's positive outlook, recent data indicates that Science Applications International Corp holds a market capitalization of $6.97 billion, with a P/E ratio standing at 25.12, signaling robust investor confidence in the firm’s earnings potential. The revenue for the past twelve months as of Q2 2025 reached $7.297 billion, accompanied by a gross profit margin of 11.57%, reflecting opportunities for further improvement aligned with their focus on value-centered work.

Commitment to Shareholders

The firm has maintained consistent dividend payments for an impressive 12 years, showcasing a dedicated approach to shareholder value. This commitment resonates with JPMorgan's observations of SAIC's strong free cash flow and management's emphasis on returning value to shareholders. Notably, aggressive share buyback initiatives by the management are poised to enhance earnings per share and support stock price stability.

Performance Metrics and Investor Considerations

The stock has illustrated commendable returns, recording a total price return of 21.26% over the past three months, and an even more impressive return of 33.28% year-over-year. This positive momentum reinforces JPMorgan's upgraded stance and elevated price target. However, potential investors should remain vigilant as technical indicators like the RSI suggest that the stock may currently be overbought, signaling a possible short-term retracement.

Frequently Asked Questions

What recent changes did JPMorgan make regarding SAIC's stock rating?

JPMorgan upgraded Science Applications' stock from Neutral to Overweight and raised its price target to $170.00.

What factors contributed to SAIC's recent financial performance?

SAIC's financial performance has significantly improved due to a strategic focus on high-value work and a robust increase in submitted bids.

How much is SAIC's qualified pipeline currently worth?

SAIC's qualified pipeline has expanded to approximately $130 billion.

What is the anticipated growth rate for SAIC in FY26?

Science Applications International Corp projects a 3% growth rate for FY26.

How has SAIC performed in terms of shareholder returns?

SAIC has consistently paid dividends for 12 consecutive years and has engaged in aggressive share buybacks to enhance shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 42

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 569

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 101

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 94

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 81

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 42

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 17

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 103

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
tion End -->

Top 5 Most Recently Viewed Articles

Investors Eye Holiday Spending Surge with Retail ETFs

Updated Category News Views 230

Holiday Spending Trends Point to Retail ETF Gains As the festive season kicks off, investors are buzzing with anticipation. The projections indicate a remarkable surge in U.S. holiday sales, expected to hit between $1.01 trillion and $1.02 trillion. This optimism is driven by strong consumer demand, early sales promotions, and a decrease in inflation, setting a promising...

Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting

Updated Category News Views 263

Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...

Continue Reading
She Said Yes Launches Eco-Friendly Jewelry Initiative

Updated Category News Views 219

She Said Yes Empowers Customers with Tree-Planting Initiative She Said Yes, a renowned jewelry brand dedicated to using conflict-free diamonds and recycled gold, has unveiled an exciting partnership with WeForest to create a meaningful environmental initiative. This new program enables every jewelry purchase to contribute directly to global reforestation efforts,...

Continue Reading
Whale Traders Target Trump Media's Future with Options Movements

Updated Category News Views 121

Whale Traders Target Trump Media's Future with Options Movements Recently, investors with substantial capital have been showing strong interest in Trump Media & Technology (NASDAQ: DJT). This surge in activity is a signal that retail traders should pay attention to. Today, unusual trading patterns have been detected, hinting that significant financial players are...

Continue Reading
Partnership Boosts Digital Transformation in Japan's Life Sciences

Updated Category News Views 153

Transforming the Life Sciences Industry through Digital Solutions ValGenesis Inc. has teamed up with Hitachi Industry & Control Solutions, Ltd. to spearhead a transformative initiative aimed at elevating the capabilities of life sciences companies in Japan. This innovative partnership intends to bring forth cutting-edge digital validation solutions to streamline processes...

Continue Reading